Tango Therapeutics, Inc. (TNGX)

Healthcare · Biotechnology · NASDAQ

Tango Therapeutics, Inc. (TNGX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $4.41B and a free-cash-flow yield of -4.5%. Over the most recent reported fiscal year, revenue grew 48.3%.

Market cap	$4.41B
Trailing P/E	—
FCF yield	-4.5%
Revenue growth (YoY)	+48.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live TNGX data on Nama Insights →